Adherence-enhancing intervention and relapse in childhood acute lymphoblastic leukemia: results from the Children’s Oncology Group randomized trial ACCL1033
Entire cohortAge at enrollment < 12 y.Baseline characteristics were comparable between participants on EDU (n = 143) and IP (n = 147) (Table 1).A median follow-up of 7.7 y (0.2-10.3) yielded a 5 y
Authors
- Lindsey Hageman (ORCID: https://orcid.org/0009-0009-2396-5634)
- Nkechi Mba
- Elizabeth A. Raetz (ORCID: https://orcid.org/0000-0002-8547-1658)
- Aman Wadhwa (ORCID: https://orcid.org/0000-0002-3245-2218)
- Smita Bhatia (ORCID: https://orcid.org/0000-0002-7755-5683)
- Paula Aristizabal
- Wendy Landier (ORCID: https://orcid.org/0000-0003-3319-5652)
- Elizabeth L. McQuaid (ORCID: https://orcid.org/0000-0001-9573-3781)
- David R. Freyer (ORCID: https://orcid.org/0000-0001-5280-990X)
- F. Lennie Wong
- Yanjun Chen
Institutions
- Children's Hospital of Los Angeles (US)
- Brown University (US)
- University of Alabama at Birmingham (US)
- University of California San Diego (US)
- NYU Langone Health (US)
- City of Hope (US)
- Driscoll Children's Hospital (US)
Publication Details
- Journal
- Leukemia
- Published
- 2026-04-13
- DOI
- https://doi.org/10.1038/s41375-026-02951-0
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- St. Baldrick's Foundation
- National Institutes of Health
- National Cancer Institute